Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.5 (
neuropathy target esterase
)
1,070
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The in vitro and in vivo biochemical properties of O-hexyl, O-dichlorophenyl phosphoramidate (hexyl-DCP) as inhibitor of acetylcholinesterase (AChE) and
neuropathy target esterase
(
NTE
) were studied, as well as their neurotoxic effects. The differences found were suggested to be due to biotransformation effects. In this work, the in vitro time-dependent degradation of hexyl-
DCP
by plasma, liver and brain homogenates of rat and hen at 37 degrees C at pH 7.4 are studied using 100 nM initial concentration. The loss of inhibitory potency against AChE was used as sensor of the biodegradation rate. An approximate estimation of the residual compound was made by comparison with an inhibition calibration curve. The rate of enzymatic degradation was corrected for the spontaneous hydrolysis. Rat tissues showed some higher activities (24, 17, 1 mU/g for plasma, liver, and brain, respectively) than hen (17, 6, 1 mU/g), with activities being highest for plasma and lowest for brain. Hexyl-
DCP
is a chiral compound. The loss of anti-AChE power could be due to degradation of only one of the two stereoisomers.
...
PMID:Hen liver and plasma can metabolize hexyl-DCP phosphoramidate at a rate comparable to that of rat. 225 3
NTE
(
neuropathy target esterase
) is considered to be the target for organophosphorus-induced delayed polyneuropathy and is operationally measured by radiolabelling or by determining its esteratic activity as the paraoxon-resistant mipafox-sensitive phosphorylable site(s). From electrophoresis and density gradient centrifugation using radiolabelling techniques, several phosphorylable sites have been described in hen brain that are paraoxon-resistant mipafox-sensitive; however, only the majority electrophoresis band (155 kDa) shows properties related with the aging reaction. Kinetic criteria have also suggested two components of brain
NTE
(NTEA and NTEB). Most brain
NTE
is recovered in the particulate microsomal fraction and only about 1% in soluble fraction. In sciatic nerve about 50%/50% activity is recovered as soluble (S-NTE) or particulate (P-NTE) forms. A similar distribution were observed in hen, cat, rat and young chick. The fixed time inhibition curves show that P-
NTE
is more sensitive to mipafox, DFP and hexyl-
DCP
than S-
NTE
, while the reverse is true for methamidophos. P-
NTE
fits properly to one sensitive component while S-
NTE
fits better to two sensitive component models, except in the case of methamidophos. In vivo, significant differences in the inhibition of P- and S-
NTE
by mipafox were found only when using low non-neuropathic dosing. The possible significance of different
NTE
forms are discussed.
...
PMID:Biochemical properties and possible toxicological significance of various forms of NTE. 834 94